XORTX Therapeutics Investor Relations Material
Latest events
Access the full event backlog
Slides, Transcripts, and Reports from 12,000+ public companies
Latest reports from XORTX Therapeutics Inc
Access all reports
XORTX Therapeutics Inc is a Canada-based clinical-stage biopharmaceutical company focused on developing therapies for chronic kidney disease and other health conditions related to abnormal purine metabolism and uric acid imbalance. The company’s lead drug candidates aim to lower serum uric acid levels to prevent or slow the progression of kidney and cardiovascular diseases. XORTX conducts research and clinical trials to advance its proprietary formulations. The company is headquartered in Calgary, Alberta, and its shares are listed on the NASDAQ.
Key slides for XORTX Therapeutics Inc
Investor Presentation
XORTX Therapeutics Inc
Investor Presentation
XORTX Therapeutics Inc
Latest articles
)
Adobe: Equipping the Architects of Digital Expression
The story of how Adobe grew from a small garage upstart to one of the largest and most dominant software companies in the world.
21 Mar 2025
)
James Quincey: Coca-Cola Chairman and CEO
James Quincey has dedicated nearly three decades to The Coca-Cola Company, rising through the ranks to become CEO and Chairman of the company.
11 Mar 2025
)
PepsiCo: From Pepsi and Gatorade to Doritos and Lay's
PepsiCo has grown from a soda company into a global leader in food and beverages, with a portfolio of over 200 brands, including Pepsi, Lay's, and Gatorade.
11 Mar 2025
Ticker symbol
XRTX
Country
🇨🇦 Canada